IGF::OT::IGF BIOEQUIVALENCY STUDIES
$379,106N01FY2016CANIH
Leidos Biomedical Research, Inc., Frederick MD
Investigators
Abstract
This project will be dedicated to evaluation of the general utility of a novel analytical method for measurement of nanomedicine drug fractions in biological matrices
View original record on NIH RePORTER →